SOBR Safe (NASDAQ: SOBR) hit with Nasdaq bid-price deficiency and delisting risk
Rhea-AI Filing Summary
SOBR Safe, Inc. reported that Nasdaq notified the company on March 19, 2026 that its common stock has failed to meet the minimum $1.00 per share bid price requirement for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2). The notice also cited prior reverse stock splits of 1‑for‑110 on October 2, 2024 and 1‑for‑10 on April 4, 2025, for a cumulative ratio of 1‑for‑1100, which makes SOBR ineligible for the standard 180‑day cure period. The company’s stock continues to trade on the Nasdaq Capital Market under the symbol SOBR, and the notice does not affect its business operations or SEC reporting. SOBR plans to timely appeal the Nasdaq staff determination to a hearings panel, submit a compliance plan, and, if needed, pursue another reverse stock split, but there is no assurance it will regain or maintain listing compliance.
Positive
- None.
Negative
- Heightened Nasdaq delisting risk: SOBR Safe is below the $1.00 bid-price requirement and, due to prior reverse splits totaling a 1‑for‑1100 ratio, is ineligible for the standard 180‑day cure period, making the appeal outcome critical for maintaining its Nasdaq listing.
Insights
Nasdaq bid-price noncompliance raises real delisting risk for SOBR.
SOBR Safe has been below Nasdaq’s $1.00 minimum bid price for 30 straight business days, triggering a deficiency notice. Because it already executed reverse splits totaling a 1‑for‑1100 ratio in the past two years, it is not eligible for the usual 180‑day grace period.
The company will appeal to a Nasdaq hearings panel and may propose another reverse split to regain compliance. A hearing request stays any suspension while the process runs, but the outcome is uncertain, and the notice explicitly warns that the securities will be scheduled for delisting absent a successful appeal.
If the appeal fails, shares could move off Nasdaq to a less liquid market, which often affects trading volume and investor access. Until the panel decides, the stock continues trading on the Nasdaq Capital Market under the symbol SOBR, and business operations and SEC reporting are described as unchanged.
FAQ
What Nasdaq issue did SOBR Safe (SOBR) disclose in this 8-K?
SOBR Safe disclosed that Nasdaq notified the company it no longer meets the $1.00 minimum bid price requirement after 30 consecutive business days below that level. This triggers a potential delisting process under Nasdaq Listing Rule 5550(a)(2).
How do SOBR Safe’s prior reverse stock splits affect its Nasdaq compliance options?
SOBR Safe completed a 1‑for‑110 reverse split in October 2024 and a 1‑for‑10 reverse split in April 2025, for a cumulative 1‑for‑1100 ratio. Because this exceeds 1‑for‑250 over two years, the company is not eligible for Nasdaq’s standard 180‑day bid-price cure period.
Is SOBR Safe’s stock being immediately delisted from Nasdaq after the notice?
No, the company states the notification has no immediate effect on its Nasdaq listing. SOBR Safe’s common stock continues to trade on the Nasdaq Capital Market under the symbol SOBR while it pursues an appeal and any panel process.
What actions does SOBR Safe plan to take in response to the Nasdaq deficiency letter?
The company plans to timely appeal the Nasdaq staff determination to a hearings panel and submit a plan to regain compliance with the bid-price rule. If necessary, it also indicates it may effect another reverse stock split as part of that plan.
Does the Nasdaq bid-price notice affect SOBR Safe’s business operations or SEC reporting?
The company states that the Nasdaq notification does not affect its business operations or its reporting obligations with the SEC. The primary risk disclosed relates to potential future delisting if compliance is not regained.
What happens if SOBR Safe does not successfully appeal the Nasdaq determination?
The letter states that, unless SOBR Safe timely appeals, Nasdaq will schedule its securities for delisting and suspend trading. Even with an appeal, there is no assurance the company will regain compliance or continue meeting all Nasdaq listing requirements.
Filing Exhibits & Attachments
5 documents